8.30am-5.30pm EDT | 5.30am-2.30pm PDT

8:00 am Registration & Networking

9:10 am Chair’s Opening Remarks

9:15 am Developing a Suite of Coarse-Grained Molecular Models for Protein Candidate Selection

• Chris Roberts Professor - Chemical & Biomolecular Engineering, University of Delaware

9:45 am Computational Design of Antibodies Against Spike Epitopes of SARS-CoV-2

• Costas Maranas Professor, Department of Chemical Engineering, The Pennsylvania State University

10:15 am Speed Networking & Morning Networking Break

11:00 am Schrödinger Case Study

• Representative , Schrödinger

11:30 am The Many-Body Physics of Antibody Formulation

• Jeremy Schmit Associate Professor, Kansas State University

12:00 pm AI-Driven Antibody Diversity to Explore Discovery & Developability

• Randal Ketchem Vice President - Molecular Design, Just Biotherapeutics

12:30 pm Networking Lunch

1:45 pm Generative Machine Learning for Design of Peptides & Peptidomimetics

• Ho Leung Ng Associate Professor - Biochemistry & Molecular Biophysics, Kansas State University

2:15 pm On-Application Technology Advantage of Computational Design: a COVID-19 Example

• Dea Shahinas CEO, Deep Biologics

2:45 pm Afternoon Networking & Poster Session

3:30 pm Roundtable Discussion

4:15 pm Biopharmaceutical Informatics: A Unified Approach to Biologic Drug Design, Discovery & Development

• Sandeep Kumar Senior Research Fellow (Biotherapeutics) & Group Leader, Boehringer Ingelheim

4:45 pm The Real Value & Opportunities in End-to-End Computational Drug Development for Biologics

• Neeraj Agrawal Senior Scientist, Group Lead of Attribute Science Data Engineering , Amgen

5:15 pm Close of Conference Day 2